DGAP-Adhoc: Symrise AG: Dr Winfried Steeger - new Chairman of the Supervisory Board
|
DGAP-Ad-hoc: Symrise AG / Key word(s): Personnel
Symrise AG: Dr Winfried Steeger - new Chairman of the Supervisory Board
07-Aug-2019 / 15:56 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Dr Winfried Steeger has been elected as new chairman of the supervisory board on August 7th 2019.
Dr Steeger is a member of the supervisory board since May 15th 2012. In addition he is also a member of the audit committee since September 20th, 2012. He has been elected as a member of the supervisory board until the end of the general meeting that decides on discharges for the 2019 fiscal year.
The previous chairman of the supervisory board, Dr Thomas Rabe, has decided to resign as chairman of the supervisory board with effect as of the end of the supervisory board meeting of August 7th 2019. He will remain and continue as member of the supervisory board. The resignation of Dr Rabe as chairman of the supervisory board is connected to his election as member of the supervisory board of Adidas in the general meeting of Adidas on May 9th 2019.
Contact:
Tobias Erfurth, Investor Relations
07-Aug-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
|
| Language: |
English |
| Company: |
Symrise AG |
|
Mühlenfeldstraße 1 |
|
37603 Holzminden |
|
Germany |
| Phone: |
+49 (0)5531 90 0 |
| E-mail: |
[email protected] |
| Internet: |
www.symrise.com |
| ISIN: |
DE000SYM9999, DE000SYM7787, DE000SYM7704 |
| WKN: |
SYM999 |
| Indices: |
MDAX |
| Listed: |
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: |
853653 |
| |
| End of Announcement |
DGAP News Service |
853653 07-Aug-2019 CET/CEST
|
Die wichtigsten Finanzdaten auf einen Blick
|
| |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023e |
| Umsatzerlöse1 |
2.996,29 |
3.154,03 |
3.407,85 |
3.520,45 |
3.825,69 |
4.618,48 |
4.730,19 |
| EBITDA1,2 |
630,31 |
630,52 |
685,07 |
742,08 |
813,62 |
795,42 |
851,65 |
| EBITDA-Marge3 |
21,04 |
19,99 |
20,10 |
21,08 |
21,27 |
17,22 |
|
| EBIT1,4 |
431,59 |
433,97 |
455,35 |
487,51 |
558,96 |
503,98 |
559,36 |
| EBIT-Marge5 |
14,40 |
13,76 |
13,36 |
13,85 |
14,61 |
10,91 |
11,83 |
| Jahresüberschuss1 |
275,65 |
297,69 |
297,88 |
314,95 |
385,03 |
290,70 |
344,94 |
| Netto-Marge6 |
9,20 |
9,44 |
8,74 |
8,95 |
10,06 |
6,29 |
7,29 |
| Cashflow1,7 |
396,18 |
441,79 |
546,76 |
635,68 |
521,56 |
360,11 |
719,51 |
| Ergebnis je Aktie8 |
2,06 |
2,08 |
2,12 |
2,22 |
2,70 |
2,00 |
2,44 |
| Dividende8 |
0,88 |
0,90 |
0,95 |
0,97 |
1,02 |
1,10 |
0,85 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen. 
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: Ernst & Young
|
| INVESTOR-INFORMATIONEN |
| ©boersengefluester.de |
| Symrise |
| WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
| SYM999 |
102,700 |
Halten |
14.354,59 |
| KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
| 30,21 |
38,34 |
0,79 |
45,87 |
| KBV |
KCV |
KUV |
EV/EBITDA |
| 4,13 |
19,95 |
3,03 |
19,99 |
| Dividende '22 in € |
Dividende '23e in € |
Div.-Rendite '23e
in % |
Hauptversammlung |
| 1,10 |
1,10 |
1,07 |
15.05.2024 |
| Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
| 25.04.2024 |
01.08.2024 |
24.10.2024 |
06.03.2024 |
| Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
| 0,87% |
5,44% |
3,07% |
-3,07% |
|
|
Symrise AG DE000SYM9999